Breast MRI, An Issue of Magnetic Resonance Imaging Clinics
268 pages
English

Vous pourrez modifier la taille du texte de cet ouvrage

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Breast MRI, An Issue of Magnetic Resonance Imaging Clinics , livre ebook

-

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus
268 pages
English

Vous pourrez modifier la taille du texte de cet ouvrage

Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

This publication presents topics on Current Clinical Indications for Breast MRI; How to set up breast MRI practice; MR-BIRADS Lexicon; Optimization of breast MRI at 1.5 Tesla(T) and at 3 Tesla; Role of MRI in evaluating extent of disease; Update on Screening breast MRI in high risk women; MRI of DCIS; Role of breast MRI in the assessment of Invasive lobular carcinoma; Breast MRI Interventions: Indications, Technique, and Histologic Correlation; Role of Breast MRI in problem-solving; Benign lesions detected on breast MRI; Clinical Oncologic Perspective of Breast MRI; Role of breast MRI in neo-adjuvant chemotherapy.


Sujets

Informations

Publié par
Date de parution 21 juin 2010
Nombre de lectures 0
EAN13 9781455700417
Langue English
Poids de l'ouvrage 3 Mo

Informations légales : prix de location à la page 0,5637€. Cette information est donnée uniquement à titre indicatif conformément à la législation en vigueur.

Extrait

Magnetic Resonance Imaging Clinics of North America , Vol. 18, No. 2, May 2010
ISSN: 1064-9689
doi: 10.1016/j.mric.2010.04.001

CME Accreditation Page and Author Disclosure


Goal Statement
The goal of Magnetic Resonance Imaging Clinics of North America is to keep practicing physicians up to date with current clinical practice by providing timely articles reviewing the state of the art in patient care.

Accreditation
The Magnetic Resonance Imaging Clinics of North America is planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Virginia School of Medicine and Elsevier. The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Virginia School of Medicine designates this educational activity for a maximum of 15 AMA PRA Category 1 Credits™ for each issue, 60 credits per year. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for a maximum of 15 AMA PRA Category 1 Credits™ for each issue, 60 credits per year.
Credit can be earned by reading the text material, taking the CME examination online at http://www.theclinics.com/home/cme , and completing the evaluation. After taking the test, you will be required to review any and all incorrect answers. Following completion of the test and evaluation, your credit will be awarded and you may print your certificate.

Faculty Disclosure/Conflict of Interest
The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.
The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
All authors/editors participating in an accredited CME activity are expected to disclose to the readers relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.). The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the reader. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia.
The faculty and staff of the University of Virginia Office of Continuing Medical Education have no financial affiliations to disclose.
The authors/editors listed below have identified no professional or financial affiliations for themselves or their spouse/partner:
Sara Bloom, MD; C. Boetes, MD, PhD; Manjil Chatterji, MD; Eduard de Lange, MD (Test Author); Wendy B. DeMartini, MD; Sara C. Gavenonis, MD; Robert L. Gutierrez, MD; Joanne Husovski (Acquisitions Editor); Nola Hylton, PhD; Vivian S. Lee, MD, PhD, MBA (Consulting Editor); H. Carisa Le-Petross, MD, FRCPC; Jessica W.T. Leung, MD; Ritse M. Mann, MD; Cecilia L. Mercado, MD (Guest Editor); Monica Morrow, MD; Linda Moy, MD (Guest Editor); Liane E. Philpotts, MD; Sughra Raza, MD; Susan Orel Roth, MD; Lynne Steinbach, MD (Consulting Editor); Eren D. Yeh, MD
The authors/editors listed below identified the following professional or financial affiliations for themselves or their spouse/partner:
Peter R. Eby, MD is an industry funded research/investigator for GE Healthcare, Ethicon Endo-Surgery, Inc., and Philips Medical.
Constance D. Lehman, MD, PhD is on the Speakers’ Bureau and the Advisory Committee/Board for General Electric.
Mary C. Mahoney, MD is on the Speakers’ Bureau for Ethicon Endo-Surgery and SenoRx, and is on the Advisory Committee/Board of Hologic.
Virginia Molleran, MD is on the Speakers Bureau for SenoRx.
Suresh Mukherji, MD (Consulting Editor) is a consultant for Philips.
Gillian M. Newstead, MD is an industry funded research/investigator for Philips Health Care, serves on the Advisory Board for Naviscan, and his spouse is a minor stockholder in Hologic.
Disclosure of Discussion of non-FDA approved uses for pharmaceutical products and/or medical devices:
The University of Virginia School of Medicine, as an ACCME provider, requires that all faculty presenters identify and disclose any “off label” uses for pharmaceutical and medical device products. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.

To Enroll
To enroll in the Magnetic Resonance Imaging Clinics of North America Continuing Medical Education program, call customer service at 1-800-654-2452 or visit us online at www.theclinics.com/home/cme . The CME program is available to subscribers for an additional fee of $99.95.
Magnetic Resonance Imaging Clinics of North America , Vol. 18, No. 2, May 2010
ISSN: 1064-9689
doi: 10.1016/S1064-9689(10)00020-6

Contributors
Magnetic Resonance Imaging Clinics of North America
Breast MRI
Linda Moy
Department of Radiology, New York University School of Medicine, 160 East 34th Street, New York, NY 10016, USA
Cecilia L. Mercado
Department of Radiology, New York University School of Medicine, 160 East 34th Street, New York, NY 10016, USA
ISSN  1064-9689
Volume 18 • Number 2 • May 2010

Contents
Cover
CME Accreditation Page and Author Disclosure
Contributors
Forthcoming Issues
Preface
Breast Magnetic Resonance Imaging: Current Clinical Indications
The BI-RADS Breast Magnetic Resonance Imaging Lexicon
Implementing a Breast MR Imaging Program: All Things Considered
Role of Magnetic Resonance Imaging in Evaluating the Extent of Disease
Optimizing 1.5-Tesla and 3-Tesla Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Breasts
MR Imaging of Ductal Carcinoma In Situ
Update on Screening Breast MRI in High-Risk Women
Role of Breast MR Imaging in Neoadjuvant Chemotherapy
The Effectiveness of MR Imaging in the Assessment of Invasive Lobular Carcinoma of the Breast
A Clinical Oncologic Perspective on Breast Magnetic Resonance Imaging
MR Imaging in the Evaluation of Equivocal Clinical and Imaging Findings of the Breast
Probably Benign Lesions Detected on Breast MR Imaging
MR Intervention: Indications, Technique, Correlation and Histologic
Index
Magnetic Resonance Imaging Clinics of North America , Vol. 18, No. 2, May 2010
ISSN: 1064-9689
doi: 10.1016/S1064-9689(10)00022-X

Forthcoming Issues
Magnetic Resonance Imaging Clinics of North America , Vol. 18, No. 2, May 2010
ISSN: 1064-9689
doi: 10.1016/j.mric.2010.02.014

Preface

Cecilia L. Mercado, MD
Department of Radiology, New York University School of Medicine, 160 East 34th Street, New York, NY 10016, USA
E-mail address: cecilia.mercado@nyumc.org
E-mail address: linda.moy@nyumc.org

Linda Moy, MD ,
Department of Radiology, New York University School of Medicine, 160 East 34th Street, New York, NY 10016, USA
E-mail address: cecilia.mercado@nyumc.org
E-mail address: linda.moy@nyumc.org


Cecilia L. Mercado, MD Guest Editor

Linda Moy, MD Guest Editor
In recent years, great advancements have occurred in breast imaging that can be attributed to the marked technological improvements in magnetic resonance (MR) imaging of the breast and to an increase in its usefulness in the evaluation and management of breast disease.
The first part of this publication focuses on the clinical indications and usefulness of breast MR imaging. One of the first articles reviews the BI-RADS Breast MRI lexicon and illustrates various MR imaging descriptors. The content also provides an update on screening of high-risk patients with breast MR and offers valuable information on the management of probably benign lesions identified on breast MR imaging. In addition, the role of MR imaging in the evaluation of specific pathologic entities, such as invasive lobular carcinoma and ductal carcinoma in situ, is discussed. The role of breast MR imaging in the management of patients with breast cancer when evaluating extent of disease and in the management of patients undergoing neoadjuvant chemotherapy is discussed in other articles in this series. The use of breast MR imaging as a problem-solving tool when evaluating selected equivocal clinical and imaging findings is also discussed.
The publication provides valuable information and useful guidelines for the implementation of a breast MR imaging program. Clinical indications and the technique of MR interventional procedures and optimization of MR imaging at the 1.5 Te

  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents